NCT06295042

Brief Summary

Current literature on complications and health-related quality of life in autologous and alloplastic breast reconstruction is inconclusive. Despite the great demand for more in-depth, long-term studies of both techniques, current evidence is low or moderate and there are only few studies focusing on both health-related quality of life and complication rates in the same patient collective. This study aims at investigating the complex relationship between the occurrence of complications and patient-reported long-time satisfaction in autologous and alloplastic breast reconstruction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
162

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 28, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

February 27, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

4.1 years

First QC Date

February 27, 2024

Last Update Submit

March 5, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complications

    The five-level modified Clavien-Dindo classification is used to objectively classify postoperative complications. A subgroup analysis will be done for complications requiring revision surgery under general anesthesia and complications not requiring revision surgery under general anesthesia.

    Retrospective data analysis at the time of study inclusion (up to 10 years postoperative)

Secondary Outcomes (1)

  • Health-related quality of life and satisfaction

    Retrospective data analysis at the time of study inclusion (up to 10 years postoperative)

Study Arms (2)

Autologous Breast Reconstruction

Patients undergoing autologous breast reconstruction with free flaps

Other: BREAST-Q Questionnaire

Alloplastic Breast Reconstruction

Patients undergoing alloplastic breast reconstruction with implants or expander prosthesis

Other: BREAST-Q Questionnaire

Interventions

Patient-reported outcome measure

Alloplastic Breast ReconstructionAutologous Breast Reconstruction

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Female breast cancer patients between 18 and 80 years who underwent autologous or alloplastic breast reconstruction at our department, willing to participate in this study.

You may qualify if:

  • female breast cancer patient undergoing autologous or alloplastic breast reconstruction willing to participate in this study
  • age between 18 and 80 years (upper limit due to indication for breast reconstruction)
  • written informed consent

You may not qualify if:

  • Missing or insufficient information
  • combination of reconstruction techniques on the same breast
  • reconstruction procedures with insufficient number of cases
  • inability to fully understand study procedures and to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Graz

Graz, 8036, Austria

Location

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 6, 2024

Study Start

October 10, 2019

Primary Completion

November 28, 2023

Study Completion

February 1, 2024

Last Updated

March 6, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA).

Shared Documents
SAP, CSR
Time Frame
Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis

Locations